Apr 27, 2023 / NTS GMT
Presentation
Apr 27, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Naoki Okamura
Astellas Pharma Inc. - President, CEO,CFO & Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
* Yoshitsugu Shitaka
Astellas Pharma Inc. - Chief Scientific Officer & Senior Managing Executive Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division -
Astellas Pharma Inc
(STU:YPH)
€
11.3
-0.10 (-0.88%)
Market Cap: 20.83 Bil
Enterprise Value: 22.33 Bil
PE Ratio: 13.32
PB Ratio: 2.12
GF Score: 84/100 Full Year 2023 Astellas Pharma Inc Earnings Presentation Transcript
Apr 27, 2023 / NTS GMT
Release Date Price:
€13.26
(-1.16%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot